Cantitate/Preț
Produs

3D Printing: Emerging Technologies and Functionality of Polymeric Excipients in Drug Product Development: AAPS Advances in the Pharmaceutical Sciences Series, cartea 44

Editat de Michael A. Repka, Nigel Langley
en Limba Engleză Hardback – 2 dec 2023
This inclusive text describes 3D Printing for pharmaceutical applications, including emerging 3D technologies. The book focuses on the functionality of the materials/biomaterials used for the preparation of dosage forms and devices, fundamentals for preparing these systems and novel applications using these additive manufacturing techniques.  Also, the text includes clinical relevance and regulatory considerations for the future of personalized medicine.

Authored by experts with a broad range of experience, extensive insight into the science of 3D printing technology used to produce these systems is provided.  Highlighting viewpoints from the academic, polymer excipient, equipment, product development and regulatory communities, this comprehensive text compiles input from industry thought leaders to illustrate strategies and technologies for applying techniques of additive manufacturing for drug product and device development whilealso providing insight into the path forward for the technology in years to come.  
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 67939 lei  38-44 zile
  Springer – 3 dec 2024 67939 lei  38-44 zile
Hardback (1) 96624 lei  43-57 zile
  Springer International Publishing – 2 dec 2023 96624 lei  43-57 zile

Din seria AAPS Advances in the Pharmaceutical Sciences Series

Preț: 96624 lei

Preț vechi: 117834 lei
-18%

Puncte Express: 1449

Preț estimativ în valută:
17106 19919$ 14860£

Carte tipărită la comandă

Livrare economică 23 februarie-09 martie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783031460142
ISBN-10: 3031460146
Pagini: 288
Ilustrații: XI, 288 p. 100 illus., 94 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.6 kg
Ediția:1st ed. 2024
Editura: Springer International Publishing
Colecția Springer
Seria AAPS Advances in the Pharmaceutical Sciences Series

Locul publicării:Cham, Switzerland

Cuprins

Overview of Pharmaceutical 3D Printing Technologies.- Clinical Benefit of 3D Printed Products.- Characterization or Quality Control of 3D Printed Products.- Polymers for HME based 3D Printing.- Cellulosic Polymers.-  API and Polymer Selection Formulation and Process Variables.-  Fused Deposition Modeling 3D Printing.-Semi-solid Extrusion Printing and 3D.-  Future Trends Including Novel Polymeric Excipients  Designed for Purpose Bioprinting.

Notă biografică

Dr. Michael A. Repka is Distinguished Professor of the Department of Pharmaceutics at The University of Mississippi. He is also Founder and Director of the Pii Center for Pharmaceutical Technology. His research interests include the solubilization and delivery of poorly soluble bioactives via Hot Melt Extrusion (HME) technology, while coupling HME techniques with 3D printing to produce patient centric delivery systems . Dr. Repka has established himself as an expert in this major pharmaceutical processing field through his numerous peer-reviewed publications, presentations and scientific talks.

Dr. Nigel Langley is currently the Global Technical Director, Life Sciences at Gaylord Chemical LLC. He has a strong interest in excipient innovation, solubilization, hot melt extrusion and 3D printing.  Dr. Langley has also worked at BASF and Croda International PLC and is the current Chair of IPEC-Americas. 

Textul de pe ultima copertă

This book is an educational text and guide for the use and properties of key polymeric excipients in the area of 3D printing in drug development. It is written by both industry experts and academic researchers.  The particular focus is on hot melt extrusion and the extruded filaments suitable for optimizing the 3D printing in drug development. 3D Printing Polymeric Excipients, Technology, and Drug Formulation Development covers regulatory aspects as well as the manufacturing aspects.

Caracteristici

Covers regulatory and manufacturing aspects of 3D printing in drug development Particular focus on hot melt extrusion and extruded filaments suitable for optimizing 3D printing Thorough short text and guide for use on the production line of 3D printing of pharmaceuticals